Loading...

NEXT Biometrics Group ASA

NXTBFPNK
Technology
Semiconductors
$0.73
$0.22(43.14%)

NEXT Biometrics Group ASA (NXTBF) Financial Performance & Income Statement Overview

Review NEXT Biometrics Group ASA (NXTBF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
109.29%
109.29%
Operating Income Growth
39.64%
39.64%
Net Income Growth
40.59%
40.59%
Operating Cash Flow Growth
-8.96%
8.96%
Operating Margin
-70.94%
70.94%
Gross Margin
10.18%
10.18%
Net Profit Margin
-68.91%
68.91%
ROE
-26.36%
26.36%
ROIC
-27.48%
27.48%

NEXT Biometrics Group ASA (NXTBF) Income Statement & Financial Overview

View the income breakdown for NEXT Biometrics Group ASA NXTBF across both annual and quarterly reports.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$13.26M$27.58M$18.29M$12.80M
Cost of Revenue$5.49M$13.34M$15.33M$20.11M
Gross Profit$7.77M$14.24M$2.96M-$7.31M
Gross Profit Ratio$0.59$0.52$0.16-$0.57
R&D Expenses$5.90M$4.76M$5.17M$4.43M
SG&A Expenses$6.62M$2.88M$3.11M$3.96M
Operating Expenses$24.25M$15.68M$10.15M$8.41M
Total Costs & Expenses$29.74M$29.02M$25.48M$28.52M
Interest Income$0.00$0.00$371000.00$292000.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$1.19M$1.15M$1.54M$1.53M
EBITDA-$15.29M-$298000.00-$4.91M-$14.19M
EBITDA Ratio-$1.15-$0.01-$0.27-$1.11
Operating Income-$16.48M-$1.44M-$7.19M-$15.72M
Operating Income Ratio-$1.24-$0.05-$0.39-$1.23
Other Income/Expenses (Net)$430000.00$139000.00$1.11M$293000.00
Income Before Tax-$16.05M-$1.30M-$6.08M-$15.43M
Income Before Tax Ratio-$1.21-$0.05-$0.33-$1.20
Income Tax Expense$99000.00$66000.00-$26000.00$59000.00
Net Income-$16.15M-$1.37M-$6.05M-$15.49M
Net Income Ratio-$1.22-$0.05-$0.33-$1.21
EPS-$0.14-$0.01-$0.06-$0.15
Diluted EPS-$0.14-$0.01-$0.06-$0.15
Weighted Avg Shares Outstanding$115.34M$100.85M$100.85M$103.25M
Weighted Avg Shares Outstanding (Diluted)$115.34M$100.85M$100.85M$103.25M

Over the last four quarters, NEXT Biometrics Group ASA achieved steady financial progress, growing revenue from $12.80M in Q1 2024 to $13.26M in Q4 2024. Gross profit stayed firm with margins at 59% in Q4 2024 versus -57% in Q1 2024. Operating income totaled -$16.48M in Q4 2024, maintaining a -124% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$15.29M. Net income dropped to -$16.15M, with EPS at -$0.14. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;